Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Healthcare Agencies II

Healthcare Agencies II

There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...

Retrovirus Life Cycles

Retrovirus Life Cycles

Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...

Sexually Transmitted Infections

Sexually Transmitted Infections

Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...

Pulmonary Tuberculosis I

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

Inhibitors of Virion Maturation and Assembly

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...

Pulmonary Tuberculosis V

Pulmonary Tuberculosis V

Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Healthcare provider approaches to managing the health harms of xylazine: A qualitative study.

Journal of substance use and addiction treatment·2026

Same author

An initial exploration of the daily associations between opioid use and acute suicide risk: The role of posttraumatic stress symptoms.

Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors·2026

Same author

Business and Service Provider Attitudes Towards Police Involvement in Overdose Response: A Cross-Sectional Survey in Rhode Island Overdose Hotspots.

Journal of community health·2026

Same author

Incarcerated geriatric patients' experiences of aging and healthcare.

Scientific reports·2026

Same author

Impact of enhanced practices on opioid overdose deaths: A community-based modeling approach.

Addiction (Abingdon, England)·2026

Same author

Utilizing the "72-Hour Rule" to Expand Rapid, Higher Dose Initiation of Methadone in a Hospital-Based Bridge Clinic.

Substance use & addiction journal·2025

Search research articles

Related Experiment Video

Updated: Jun 8, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

HIV treatment in US prisons.

Sarah E Wakeman¹, Josiah D Rich

¹Massachusetts General Hospital, Department of Medicine, Boston, MA, USA.

|October 19, 2010

Summary

Prisoners disproportionately suffer from HIV, presenting a critical public health challenge. Addressing HIV in correctional facilities offers a unique opportunity for testing, treatment, and prevention in hard-to-reach populations.

Area of Science:

Public Health
Infectious Diseases
Correctional Healthcare

Background:

Incarcerated populations exhibit a disproportionately high burden of infectious diseases, notably HIV.
High-risk groups for HIV, including minorities and those with addiction or mental illness, are overrepresented in prisons.
This concentration offers a unique opportunity for HIV intervention among hard-to-reach individuals.

Purpose of the Study:

To highlight the public health importance of providing HIV care within correctional facilities.
To discuss the unique challenges and barriers to optimal HIV care delivery in prisons.
To explore practical strategies for implementing HIV services in correctional settings.

Main Methods:

Literature review on HIV prevalence in correctional populations.

More Related Videos

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Related Experiment Videos

Last Updated: Jun 8, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings

Published on: March 30, 2014

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Rapid Screening of HIV Reverse Transcriptase and Integrase Inhibitors

Published on: April 9, 2014

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Oral Combinational Antiretroviral Treatment in HIV-1 Infected Humanized Mice

Published on: October 6, 2022

Analysis of barriers to HIV care in prisons (confidentiality, medication access, discharge planning).

Discussion of public health implications and practical considerations for HIV management in correctional facilities.

Main Results:

Correctional facilities concentrate populations at high risk for HIV, offering a crucial point for intervention.
Significant barriers exist, including issues with confidentiality, medication access, and continuity of care post-release.
Effective HIV care within prisons requires addressing these specific environmental and systemic challenges.

Conclusions:

Providing comprehensive HIV care in prisons is a critical public health imperative.
Overcoming barriers to care within correctional facilities is essential for effective HIV prevention and treatment.
Integrated strategies are needed to ensure continuity of HIV care for incarcerated individuals.